PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
18-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Inc
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi
18-Oct-2024 PUBLICATION DEMONSTRATES POTENTIAL FOR MULTI-MARKER CTC PROFILING IN EARLY PROSTATE CANCER ANGLE plc
18-Oct-2024 SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878 SciRhom GmbH
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi and Orano Med
18-Oct-2024 EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries EVERSANA
18-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Ltd
18-Oct-2024 Blue Mountain Announces Launch of Blue Mountain University: A Premier e-Learning Experience for RAM Software Users Blue Mountain
18-Oct-2024 Genomics releases new research showing significant link between genetic risk and obesity Genomics plc
17-Oct-2024 Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a stem-cell derived bone graft alternative Andrew Lloyd Associates
17-Oct-2024 Yourgene Health Cystic Fibrosis Base Assay Receives IVDR Accreditation Yourgene Health
17-Oct-2024 Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry Alfa Chemistry
17-Oct-2024 CD Formulation: Nanoparticle Technology Heralds New Breakthroughs in Pharmaceutical Innovation CD Formulation
17-Oct-2024 CD Formulation—Provider of Contract Development and Manufacturing Services for Innovative Oral Film Products CD Formulation
16-Oct-2024 ViiV Healthcare shows more than 99% effectiveness in real-world studies for Apretude (cabotegravir long-acting), the only approved long-acting HIV PrEP, in data presented at IDWeek 2024 ViiV Healthcare
16-Oct-2024 OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain OKYO Pharma Limited
16-Oct-2024 Biocomposites invests in InfectoTest GmbH – developers of a bacterial-specific point-of-care test for periprosthetic joint infection (PJI) Biocomposites
16-Oct-2024 Ikerian Announces Series B Funding First close of USD 8M (CHF 6.73M) Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe Ikerian AG
16-Oct-2024 Gepotidacin accepted for priority review by US FDA for treatment of uncomplicated urinary tract infections in female adults and adolescents GSK plc
16-Oct-2024 53Biologics Awarded Best Company in Biotechnology Innovation at Farmaforum 53Biologics